This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Brainstorms

Neurotransmission of Cognition, Part 3. Mechanism of Action of Selective NRIs: Both Dopamine and Norepinephrine Increase in Prefrontal Cortex

Stephen M. Stahl, MD, PhD

Published: March 15, 2003

Article Abstract
Brainstorms: Neurotransmission of Cognition, Part 3. Mechanism of Action of Selective NRIs: Both Dopamine and Norepinephrine Increase in Prefrontal Cortex.

New discoveries about how dopamine and norepinephrine are regulated in the prefrontal cortex (PFC) run counter to classical pharmacologic expectations of how these neurotransmitters act in the rest of the brain. In the PFC, dopamine reuptake inhibitors do not increase dopamine, but norepinephrine reuptake inhibitors (NRIs) do. The nature of counterintuitive findings like these can be initially confusing, but when understood, they are striking and can lead to a paradigm shift in the way in which psychopharmacology is applied to develop novel treatments. Just such a situation is the case for the new selective NRI atomoxetine.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 64

Quick Links: Epilepsy , Neurodevelopmental

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived...

Read More...